{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:42:18Z","timestamp":1767138138756,"version":"3.48.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,30]]},"DOI":"10.7759\/cureus.100438","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:37:17Z","timestamp":1767137837000},"source":"Crossref","is-referenced-by-count":0,"title":["Selective Serotonin Reuptake Inhibitors (SSRIs), Childhood and Adolescent Depression, and Suicidality Following the FDA's 2004 Black Box Warning: A Systematized Literature Review"],"prefix":"10.7759","author":[{"given":"Harlin","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aksha","family":"Memon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Data and statistics on children's mental health. (2025). Accessed. September 13, 2025: https:\/\/www.cdc.gov\/children-mental-health\/data-research\/index.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_414_17","article-title":"The role of online social networking on deliberate self-harm and suicidality in adolescents: a systematized review of literature","volume":"60","author":"Memon AM","year":"2018","unstructured":"Memon AM, Sharma SG, Mohite SS, Jain S. The role of online social networking on deliberate self-harm and suicidality in adolescents: a systematized review of literature. Indian J Psychiatry. 2018, 60:384-92. 10.4103\/psychiatry.IndianJPsychiatry_414_17","journal-title":"Indian J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.3074","article-title":"National trends in the mental health care of children, adolescents, and adults by office-based physicians","volume":"71","author":"Olfson M","year":"2014","unstructured":"Olfson M, Blanco C, Wang S, Laje G, Correll CU. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry. 2014, 71:81-90. 10.1001\/jamapsychiatry.2013.3074","journal-title":"JAMA Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.9058se1c.04gry","article-title":"Major depressive disorder treatment guidelines in America and Europe","volume":"71","author":"Davidson JR","year":"2010","unstructured":"Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010, 71:e04. 10.4088\/JCP.9058se1c.04gry","journal-title":"J Clin Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e318145ae1c","article-title":"Practice parameter for the assessment and treatment of children and adolescents with depressive disorders","volume":"46","author":"Birmaher B","year":"2007","unstructured":"Birmaher B, Brent D, Bernet W, et al.. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007, 46:1503-26. 10.1097\/chi.0b013e318145ae1c","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30137-1","article-title":"Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis","volume":"7","author":"Zhou X","year":"2020","unstructured":"Zhou X, Teng T, Zhang Y, et al.. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020, 7:581-601. 10.1016\/S2215-0366(20)30137-1","journal-title":"Lancet Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012","volume":"26","author":"Bachmann CJ","year":"2016","unstructured":"Bachmann CJ, Aagaard L, Burcu M, et al.. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016, 26:411-9. 10.1016\/j.euroneuro.2016.02.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/virtualmentor.2012.14.6.pfor2-1206","article-title":"Antidepressants and the FDA's black-box warning: determining a rational public policy in the absence of sufficient evidence","volume":"14","author":"Ho D","year":"2012","unstructured":"Ho D. Antidepressants and the FDA's black-box warning: determining a rational public policy in the absence of sufficient evidence. Virtual Mentor. 2012, 14:483-8. 10.1001\/virtualmentor.2012.14.6.pfor2-1206","journal-title":"Virtual Mentor"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: an analysis of 14 review types and associated methodologies","volume":"26","author":"Grant MJ","year":"2009","unstructured":"Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009, 26:91-108. 10.1111\/j.1471-1842.2009.00848.x","journal-title":"Health Info Libr J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.0730","article-title":"Adult functional outcomes of common childhood psychiatric problems: a prospective, longitudinal study","volume":"72","author":"Copeland WE","year":"2015","unstructured":"Copeland WE, Wolke D, Shanahan L, Costello EJ. Adult functional outcomes of common childhood psychiatric problems: a prospective, longitudinal study. JAMA Psychiatry. 2015, 72:892-9. 10.1001\/jamapsychiatry.2015.0730","journal-title":"JAMA Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2018.11.275","article-title":"Major depressive disorder in children and adolescents","volume":"8","author":"Mullen S","year":"2018","unstructured":"Mullen S. Major depressive disorder in children and adolescents. Ment Health Clin. 2018, 8:275-83. 10.9740\/mhc.2018.11.275","journal-title":"Ment Health Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1408480","article-title":"Antidepressants' black-box warning--10 years later","volume":"371","author":"Friedman RA","year":"2014","unstructured":"Friedman RA. Antidepressants' black-box warning--10 years later. N Engl J Med. 2014, 371:1666-8. 10.1056\/NEJMp1408480","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6699028","article-title":"Use of antidepressants among patients diagnosed with depression: a scoping review","volume":"2021","author":"Marasine NR","year":"2021","unstructured":"Marasine NR, Sankhi S, Lamichhane R, Marasini NR, Dangi NB. Use of antidepressants among patients diagnosed with depression: a scoping review. Biomed Res Int. 2021, 2021:6699028. 10.1155\/2021\/6699028","journal-title":"Biomed Res Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani A","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018, 391:1357-66. 10.1016\/S0140-6736(17)32802-7","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6020048","article-title":"Treatment of major depressive disorder in pediatric populations","volume":"6","author":"Neavin DR","year":"2018","unstructured":"Neavin DR, Joyce J, Swintak C. Treatment of major depressive disorder in pediatric populations. Diseases. 2018, 6:48. 10.3390\/diseases6020048","journal-title":"Diseases"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X701405","article-title":"Which first-line antidepressant?","volume":"69","author":"Kendrick T","year":"2019","unstructured":"Kendrick T, Taylor D, Johnson CF. Which first-line antidepressant?. Br J Gen Pract. 2019, 69:114-5. 10.3399\/bjgp19X701405","journal-title":"Br J Gen Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07030454","article-title":"Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents","volume":"164","author":"Gibbons RD","year":"2007","unstructured":"Gibbons RD, Brown CH, Hur K, et al.. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007, 164:1356-63. 10.1176\/appi.ajp.2007.07030454","journal-title":"Am J Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.3.724","article-title":"Pediatric antidepressant use after the black-box warning","volume":"28","author":"Busch SH","year":"2009","unstructured":"Busch SH, Barry CL. Pediatric antidepressant use after the black-box warning. Health Aff (Millwood). 2009, 28:724-33. 10.1377\/hlthaff.28.3.724","journal-title":"Health Aff (Millwood)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2022.10.001","article-title":"Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders","volume":"62","author":"Walter HJ","year":"2023","unstructured":"Walter HJ, Abright AR, Bukstein OG, Diamond J, Keable H, Ripperger-Suhler J, Rockhill C. Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders. J Am Acad Child Adolesc Psychiatry. 2023, 62:479-502. 10.1016\/j.jaac.2022.10.001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref20","article-title":"Depression in Children and Young People: Identification and Management","author":"National Institute for Health and Care Excellence (NICE)","year":"2019","unstructured":"National Institute for Health and Care Excellence (NICE). Depression in Children and Young People: Identification and Management. National Institute for Health and Care Excellence (NICE), London; 2019."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-021-01179-z","article-title":"Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study","volume":"47","author":"Lagerberg T","year":"2022","unstructured":"Lagerberg T, Fazel S, Sj\u00f6lander A, Hellner C, Lichtenstein P, Chang Z. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study. Neuropsychopharmacology. 2022, 47:817-23. 10.1038\/s41386-021-01179-z","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.7.807","article-title":"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for adolescents with depression study (TADS) randomized controlled trial","volume":"292","author":"March J","year":"2004","unstructured":"March J, Silva S, Petrycki S, et al.. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA. 2004, 292:807-20. 10.1001\/jama.292.7.807","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08070976","article-title":"Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study","volume":"166","author":"Brent DA","year":"2009","unstructured":"Brent DA, Emslie GJ, Clarke GN, et al.. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry. 2009, 166:418-26. 10.1176\/appi.ajp.2008.08070976","journal-title":"Am J Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.10.1132","article-title":"The treatment for adolescents with depression study (TADS): long-term effectiveness and safety outcomes","volume":"64","author":"March JS","year":"2007","unstructured":"March JS, Silva S, Petrycki S, et al.. The treatment for adolescents with depression study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007, 64:1132-43. 10.1001\/archpsyc.64.10.1132","journal-title":"Arch Gen Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7488.389","article-title":"Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study","volume":"330","author":"Martinez C","year":"2005","unstructured":"Martinez C, Rietbrock S, Wise L, et al.. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 2005, 330:389. 10.1136\/bmj.330.7488.389","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2317","article-title":"Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts","volume":"125","author":"Schneeweiss S","year":"2010","unstructured":"Schneeweiss S, Patrick AR, Solomon DH, et al.. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics. 2010, 125:876-88. 10.1542\/peds.2009-2317","journal-title":"Pediatrics"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05885blu","article-title":"Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample","volume":"72","author":"Vitiello B","year":"2011","unstructured":"Vitiello B, Emslie G, Clarke G, et al.. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry. 2011, 72:388-96. 10.4088\/JCP.09m05885blu","journal-title":"J Clin Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00243","article-title":"Association between selective serotonin reuptake inhibitor therapy and suicidality: analysis of U.S. Food and Drug Administration adverse event reporting system data","volume":"38","author":"Umetsu R","year":"2015","unstructured":"Umetsu R, Abe J, Ueda N, et al.. Association between selective serotonin reuptake inhibitor therapy and suicidality: analysis of U.S. Food and Drug Administration adverse event reporting system data. Biol Pharm Bull. 2015, 38:1689-99. 10.1248\/bpb.b15-00243","journal-title":"Biol Pharm Bull"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30215-9","article-title":"The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial","volume":"6","author":"Davey CG","year":"2019","unstructured":"Davey CG, Chanen AM, Hetrick SE, et al.. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial. Lancet Psychiatry. 2019, 6:735-44. 10.1016\/S2215-0366(19)30215-9","journal-title":"Lancet Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/da.22329","article-title":"Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis","volume":"32","author":"Strawn JR","year":"2015","unstructured":"Strawn JR, Welge JA, Wehry AM, Keeshin B, Rynn MA. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2015, 32:149-57. 10.1002\/da.22329","journal-title":"Depress Anxiety"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.11124\/jbisrir-2015-2272","article-title":"The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review","volume":"13","author":"KoKoAung E","year":"2015","unstructured":"KoKoAung E, Cavenett S, McArthur A, Aromataris E. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review. JBI Database System Rev Implement Rep. 2015, 13:174-205. 10.11124\/jbisrir-2015-2272","journal-title":"JBI Database System Rev Implement Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013674.pub2","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","volume":"5","author":"Hetrick SE","year":"2021","unstructured":"Hetrick SE, McKenzie JE, Bailey AP, et al.. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021, 5:CD013674. 10.1002\/14651858.CD013674.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani A","year":"2016","unstructured":"Cipriani A, Zhou X, Del Giovane C, et al.. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016, 388:881-90. 10.1016\/S0140-6736(16)30385-3","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081514","article-title":"Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies","volume":"180","author":"Barbui C","year":"2009","unstructured":"Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ. 2009, 180:291-7. 10.1503\/cmaj.081514","journal-title":"CMAJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/413503-selective-serotonin-reuptake-inhibitors-ssris-childhood-and-adolescent-depression-and-suicidality-following-the-fdas-2004-black-box-warning-a-systematized-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:37:30Z","timestamp":1767137850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/413503-selective-serotonin-reuptake-inhibitors-ssris-childhood-and-adolescent-depression-and-suicidality-following-the-fdas-2004-black-box-warning-a-systematized-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.100438","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}